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Abstract
Background: Antimicrobial resistance is a public health problem of global importance. In Singapore, much focus
has been given to antibiotic usage patterns in hospital settings. Data on antibiotic use in primary care is lacking.
We describe antibiotic usage patterns and assess factors contributing to antibiotic usage among adults presenting
with acute febrile illness (AFI) in primary care settings in Singapore.
Methods: We analyzed data from the Early Dengue infection and outcome study. Adults with AFI presenting at 5
Singapore polyclinics were included. We used multivariable logistic regression to assess demographic, clinical and
laboratory factors associated with antibiotic usage among adults with AFI.
Results: Between December 2007 and February 2013, 1884 adult AFI patients were enrolled. Overall, 16% of adult AFI
patients reported antibiotic use. We observed a rise in the use of over-the-counter medications in late 2009 and a
decrease in antibiotic use during 2010, possibly related to the outbreak of pandemic influenza A H1N1 virus. After
adjusting for age, gender, polyclinic and year of enrolment, the following factors were associated with higher odds of
antibiotic use: living in landed property (compared to public housing) (OR = 1.73; 95% CI: 1.06–2.80); body mass index
(BMI) <18.5 (OR = 1.87; 95% CI: 1.19–2.93); elevated white blood cell (WBC) count (OR = 1.98; 95% CI: 1.42–2.78); and
persistence of initial symptoms at 2–3 days follow-up with OR (95% CI) for categories of 1, 2, 3, and ≥4 persisting
symptoms being 2.00 (1.38–2.92), 2.67 (1.80–3.97), 4.26 (2.73–6.64), and 2.79 (1.84–4.24) respectively.
Conclusions: Our study provides insights on antibiotic usage among adult patients presenting to primary care clinics
with febrile illness, and suggests that high socio-economic status, and risk factors of a severe illness, that is, low BMI
and persistence of initial symptoms, are associated with higher antibiotic use. Further work to understand trends of
antibiotic usage in both private and public primary care clinics, and factors that influence patient expectation and
physician prescribing of antibiotics is important.
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Background
Antimicrobial resistance (AMR) is a public health prob-
lem of global importance. The recent O’Neill review on
AMR, commissioned by the government of the United
Kingdom, suggests that the death toll from antimicrobial-
resistant infections could exceed 10 million annually by
2050, surpassing mortality from cancer [1]. Antibiotic use
is associated with AMR. [2] A systematic review by
Costelloe and colleagues showed that the greater the
number or duration of antibiotics prescribed in previous
12 months, the greater the likelihood of isolating drug-
resistant bacteria [3]. Thus, it is important to optimize the
use of antibiotics in humans and animals. This was also a
particular focus of the O’Neill review and a key re-
commendation in the 2015 World Health Organization
(WHO) Global Action Plan on AMR. [1, 4] Understan-
ding levels and determinants of antibiotic use is critical to
inform guidelines on optimal antibiotic use. Previous stud-
ies from the United States and the Netherlands reported
excessive and inappropriate use of antibiotics in primary
care [5, 6]. In Hong Kong, level of antibiotic use in pri-
mary care was generally similar to other developed set-
tings with relatively lower number of antibiotics used
among patients with upper respiratory tract infections [7].
In Singapore, much focus has been given to antibiotic
usage patterns in hospital settings while data on antibiotic
usage in primary care are lacking [8, 9]. In this paper, we
report antibiotic usage patterns and factors associated
with antibiotic usage among adult fever patients present-
ing to primary care clinics in Singapore.
Methods
Study population
We analyzed demographic, clinical and epidemiological
data from adults with acute febrile illness (AFI) enrolled in
the Early DENgue infection and outcome (EDEN) study
[10]. The aim of the EDEN study was to characterize
epidemiological, clinical, viral, and host specific features of
adult dengue disease. It was conducted at five Singapore
polyclinics which are government-subsidized, comprehen-
sive primary care clinics. Polyclinics cater for approximately
a quarter of primary care attendance in Singapore [11].
Adults (age ≥17 years) presenting to the study polyclinics
between December 2007 and February 2013 with a history
of fever (body temperature ≥38 °C) for less than 72 h were
enrolled. Data were collected using standardized data
forms. Participants were followed up on 2 separate occa-
sions at 2–3 days and 4 weeks from the initial visit. Blood
samples were collected at each visit for a range of labora-
tory diagnostics. In this analysis, AFI was defined as fever
(body temperature ≥38 °C) for not longer than 72 h at
initial presentation. Influenza-like illness (ILI) was defined
as fever and cough according to the WHO definition [12].
Hospital admissions that took place within 5 days of the
initial visit were considered due to the current AFI episode.
Antibiotic use was defined as patients’ self-reported use of
antibiotics for the illness.
Statistical analysis
We described the frequency of antibiotic usage among
AFI patients, and examined the use of over-the-counter
(OTC) medications (i.e. analgesics, cough medications
and cold remedies) and antibiotics over time. Discrete and
continuous variables were summarized using mean
(standard deviation, SD) or median and (interquartile
range, IQR) as appropriate; categorical variables were
summarized using frequencies and percentages. We inves-
tigated associations between antibiotic use among AFI pa-
tients and demographic characteristics, clinical symptoms
and laboratory parameters using χ2 statistics and p-values.
We used multivariable logistic regression to identify
factors independently associated with antibiotic use. In a
sub-group analysis, we further examined these factors
among patients meeting the WHO definition for ILI.
Variables with p-value <0.2 in the univariable analysis
were considered for inclusion in multivariable analysis.
We included age group, gender, recruiting polyclinic, and
year of enrolment as covariates in all models. We added
explanatory variables in a forward step-wise procedure,
using the likelihood ratio (LR) test to assess the contribu-
tion of each variable to the model. We retained variables
with a LR test p-value <0.05 and summarized the associ-
ation between each variable and antibiotic usage with odds
ratios (ORs) and 95% confidence intervals (CIs). Statistical
analysis was performed using Stata 12 (Stata Corp).
Results
We analyzed data from 1884 adult AFI patients enrolled in
the EDEN study between December 2007 and February
2013. The mean age of patients was 36.7 years (SD, 14.7),
1235 (66%) were male, and 958 (51%) were Chinese. Most
patients (74.3%) lived in public housing. Average body
temperature at initial presentation was 38.2 °C, median dur-
ation of illness was 5 days (IQR, 3–7), and 759 (40%) pa-
tients satisfied the WHO definition of ILI. Less than 5% of
AFI patients were known to have diabetes; other comorbid-
ities (i.e. malignancy, and ischemic heart disease) were un-
common (<1%) (Table 1).
Overall, 309 (16%) patients used antibiotics, ranging from
5 to 31% across 5 polyclinics. OTC medication was used by
56% of patients, and included use of analgesics (309, 16%),
cough medicines (608, 32%) and cold remedies (378, 20%).
Figure 1 presents the use of antibiotics and over-the-
counter medication over time. A marked drop in the per-
centage of patients who used antibiotics occurred in 2010,
with a reduction of 40% from the mean for the entire study
period in the second quarter of 2010. This coincided with
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Table 1 Characteristics and Antibiotic Use of 1884 Fever Patients
Presenting at Singapore Polyclinics, December 2007-February 2013
Characteristics N (%) Antibiotic
use, n (%)
p-value
Age in years
17–24 482 (25.6) 80 (16.6) 0.052
25–34 529 (28.1) 65 (12.3)
35–44 309 (16.4) 55 (17.8)
45–54 279 (14.8) 52 (18.6)
55–64 193 (10.2) 37 (19.2)
65 and above 92 (4.9) 20 (21.7)
Gender
Female 649 (34.4) 129 (19.9) 0.003
Male 1235 (65.6) 180 (14.6)
Year of enrolment
Dec 2007–2008 146 (7.7) 28 (19.2) 0.003
2009 232 (12.3) 53 (22.8)
2010 611 (32.4) 76 (12.4)
2011 576 (30.6) 102 (17.7)
2012-Feb 2013 319 (16.9) 50 (15.7)
Recruiting polyclinic
Polyclinic A 928 (49.3) 220 (23.7) <0.001
Polyclinic B 620 (32.9) 52 (8.4)
Polyclinic C 193 (10.2) 19 (9.8)
Polyclinic D 101 (5.4) 5 (5.0)
Polyclinic E 42 (2.2) 13 (31.0)
Body Mass Index (kg/m2)
<18.5 162 (8.6) 39 (24.1) <0.001
18.5–22.9 798 (42.4) 111 (13.9)
23–27.4 634 (33.7) 93 (14.7)
≥27.5 290 (15.4) 66 (22.8)
Ethnicity
Chinese 958 (50.8) 182 (19.0) 0.001
Indian 312 (16.6) 39 (12.5)
Malay 330 (17.5) 59 (17.9)
Other 283 (15.0) 29 (10.2)
Missing values 1 (0.1)
Housing type
Condominium 66 (3.5) 13 (19.7) <0.001
Dormitory/Hostel 228 (12.1) 9 (3.9)
Public housing (HDB flat) 1399 (74.3) 251 (17.9)
Landed Property 118 (6.3) 29 (24.6)
Work site 71 (3.8) 7 (9.9)
Missing values 2 (0.1)
Table 1 Characteristics and Antibiotic Use of 1884 Fever Patients
Presenting at Singapore Polyclinics, December 2007-February 2013
(Continued)
Duration of illness
≤5 days 1053 (55.9) 135 (12.8) <0.001
>5 days 760 (40.3) 168 (22.1)
Missing values 71 (3.8)
Diabetes
No 1797 (95.4) 286 (15.9) 0.01
Yes 87 (4.6) 23 (26.4)
Initial body temperature (° C)
<38 596 (31.6) 83 (13.9) 0.047
38–38.9 921 (48.9) 153 (16.6)
≥39 365 (19.4) 73 (20.0)
Missing values 2 (0.1)
Number of initial symptoms other than fever
0–2 280 (14.9) 27 (9.6) 0.002
3–4 487 (25.8) 74 (15.2)
5–7 657 (34.9) 118 (18.0)
8–15 460 (24.4) 90 (19.6)
Number of initial visit symptoms persisting at the first follow-upa
0 821 (43.6) 79 (9.6) <0.001
1 358 (19.0) 64 (17.9)
2 264 (14.0) 60 (22.7)
3 154 (8.2) 52 (33.8)
≥4 246 (13.1) 54 (22.0)
Missing values 41 (2.2)
Occurrence of new symptoms reported at the first follow-upa
0 1214 (64.4) 175 (14.4) 0.001
1 372 (19.7) 76 (20.4)
2 155 (8.2) 32 (20.6)
≥3 102 (5.4) 26 (25.5)
Missing values 41 (2.2)
Influenza-like illnessb
No 1123 (59.6) 160 (14.2) 0.002
Yes 759 (40.3) 149 (19.6)
Missing values 2 (0.1)
Type of employment
Not employed 365 (19.4) 61 (16.7) 0.284
Blue collar 1032 (54.8) 155 (15.0)
White collar 438 (23.2) 83 (18.9)
Other 47 (2.5) 9 (19.1)
Missing values 2 (0.1)
Season
NEM 479 (25.4) 77 (16.1) 0.821
PSWM 395 (21.0) 63 (15.9)
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increased use of OTC medication. This effect was only
temporary and was reversed from 2011 onwards.
Among AFI patients, 94% reported two or more symp-
toms at the initial presentation. Headache (69%), muscle
pain (64%), and loss of appetite (54%) were the three most
commonly reported symptoms. Vomiting, diarrhea, swollen
lymph nodes, rashes, and bleeding were each reported by
fewer than 10% of patients (Fig. 2).
In multivariable analysis, factors associated with in-
creased odds of antibiotic use, after adjusting for age,
gender, recruiting polyclinic, and year of enrolment, in-
cluded living in landed property compared to public
housing (OR = 1.73; 95% CI: 1.06–2.80); having a body
mass index (BMI) below 18.5 kg/m2 (OR = 1.87; 95% CI:
1.19–2.93), and elevated WBC count (OR = 1.98; 95%
CI: 1.42–2.78). Persistence of symptoms at 2–3 days
from initial presentation was also associated with
increased odds of antibiotic use; adjusted OR (95% CI)
for categories of 1, 2, 3, and ≥4 persisting symptoms
were 2.00 (1.38–2.92), 2.67 (1.80–3.97), 4.26 (2.73–6.64),
and 2.79 (1.84–4.24) respectively (Table 2).
In a sub-group analysis of patients who met the WHO
definition of ILI, after adjusting for age, gender, recruit-
ing polyclinic, and year of enrolment, an elevated WBC
count at initial presentation (OR = 1.97; 95% CI: 1.17–
3.33), and persistence of symptoms at 2–3 days from ini-
tial presentation [(OR = 1.42; 95% CI: 0.79–2.57), (OR =
2.30; 95% CI: 1.23–4.30), (OR = 5.12; 95% CI: 2.67–9.83),
and (OR = 2.28; 95% CI: 1.24–4.19) for categories of 1, 2,
3 and ≥4 persisting symptoms respectively] were associ-
ated with higher odds of antibiotic usage (Table 3).
Discussion
We conducted a secondary data analysis, and assessed
antibiotic use among adult fever patients in primary care
setting, and factors associated with elevated antibiotic
use. We found that overall 16% of adult AFI patients re-
ported antibiotic use, although there was considerable
variation between polyclinics. Factors that are likely to
indicate higher socioeconomic status, and factors that
are risk factors of a severe illness were associated with
higher odds of antibiotic use.
Our estimates of antibiotic usage are difficult to com-
pare to other settings, as previous studies have reported
antibiotic usage or prescription overall, rather than spe-
cifically in adult fever patients. A Malaysian study by Ab
Rahman and colleagues showed that 24% of adults were
prescribed antibiotic in primary care clinics [13]. A sur-
vey conducted in Indonesia reported that an overall 21%
patients attending public primary care centers consumed
antibiotic [14]. In the United States, antibiotic prescrip-
tion was reported in 10% of overall ambulatory visits
[15].
Our study shows that patients living in a landed prop-
erty were more likely to use antibiotics. In Singapore,
landed properties (such as terrace houses, semi-detached
houses, and bungalows) are likely to be related to higher
socioeconomic status [16]. A possible explanation to our
finding is that patients of higher socioeconomic status
were more likely to expect an antibiotic prescription
from physicians. This is consistent with the findings of a
study from the United States [17].
Having low BMI and persisting symptoms at 2–3 days
from the initial presentation were associated with a
higher odds of antibiotic usage. Prescribing clinicians
may perceive these as risk factors for more severe or
longer-lasting illness, or secondary infection [18–20],
and may be more likely to prescribe antibiotics to these
patients [6, 21].
Fever patients with elevated WBC count at initial pres-
entation were more likely to use antibiotics. A similar
Table 1 Characteristics and Antibiotic Use of 1884 Fever Patients
Presenting at Singapore Polyclinics, December 2007-February 2013
(Continued)
SWM 709 (37.6) 114 (16.1)
PNEM 301 (16.0) 55 (18.3)
Hospitalization as a result of febrile illness
Not hospitalized 1831 (97.2) 301 (16.4) 0.354
Hospitalized 53 (2.8) 8 (15.1)
WBC count at initial visit (×109 cells/L)
Leukopenia (<4) 204 (10.8) 26 (12.7) 0.001
Normal range (4–11) 1362 (72.3) 210 (15.4)
Leukocytosis (>11) 305 (16.2) 71 (23.3)
Missing values 13 (0.7)
Anemia at initial visit (hemoglobin concentration in g/dl)#
No anemia (male, ≥13; female,
≥12)
1685 (89.4) 281 (16.7) 0.702
Mild anemia (male, 11–12.9; female,
11–11.9)
121 (6.4) 17 (14.0)
Moderate anemia (8–10.9) 48 (2.5) 6 (12.5)
Severe anemia (<8) 10 (0.5) 1 (10.0)
Missing values 20 (1.1)
Platelet count at initial visit (plt/μL)
Thrombocytopenia (<150) 279 (14.8) 42 (15.1) 0.609
Normal range (150–400) 1547 (82.1) 260 (16.8)
Thrombocytosis (>400) 40 (2.1) 5 (12.5)
Missing values 18 (1.0)
HDB Housing and Development Board, NEM Northeast Monsoon Season
(December to mid-March), PSWM Pre Southwest Monsoon (mid-March to May),
SWM Southwest Monsoon (June to September), PNEM Pre Northeast Monsoon
(October to
November), WBC White Blood Cells
a2–3 days after the initial visit
bInfluenza-like illness is defined as fever of ≥38 °C and cough according to WHO [12]
#Anemia as defined by haemoglobin concentration cut-offs from World Health
Organization [28]
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Fig. 1 Use of Antibiotics and Over-the-Counter Medications Between December 2007 and February 2013
Fig. 2 Symptom profile of 1884 Fever Patients Presenting at Singapore Polyclinics, December 2007-February 2013
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association was also observed in the subgroup of pa-
tients with ILI. A high WBC count might indicate a bac-
terial infection, and thus the likelihood of antibiotic
prescription. Studies from Switzerland and China found
that more antibiotic use among fever patients was
assoiated with higher WBC count [22, 23].
Our data indicate that antibiotic use decreased markedly
in late 2009 and 2010, during which time the use of OTC
medications increased. This coincided with the period
following the epidemic of influenza A H1N1, which was in-
troduced into Singapore in May 2009 and peaked in the lat-
ter part of 2009 and early 2010 [24]. The reduction in
antibiotic use during this period could be due to heightened
awareness among primary care physicians of the H1N1
pandemic. A similar phenomenon was reported in a study
by Hebert and colleagues, in which lower antibiotic pre-
scribing was observed during a pandemic period of febrile
respiratory illness in the metropolitan Chicago area. [25]
Although this pattern of reduced antibiotic usage was re-
versed in 2011, it suggests that considerable reductions in
antibiotic prescription are possible in primary care.
The EDEN study was primarily designed to assess
Dengue virus infection patterns, and antibiotic use was
self-reported by the participants. Data on prescription,
type, dosage and timing of antibiotic use were not
available. Certain respiratory symptoms, such as cough,
were not systematically recorded, and may have led to an
underestimation of ILI.
Among fever patients in Singapore, approximately 80% of
primary care consultations take place at private institutions
[11]. The EDEN study did not sample patients visiting pri-
vate practitioners. Patients accessing public primary care
services are likely to differ from those using private services.
For example, there were notable differences between
patients in our data and the general population: 50% of
patients were Chinese and 72% lived in HDB flats com-
pared to 74% and 82% of the general population, respect-
ively [26, 27]. In addition, antibiotic prescription and usage
Table 2 Factors Associated with Antibiotic Use among 1884 Fever
Patients at Febrile Polyclinics, December 2007-February 2013
Characteristics Unadjusted
OR (95% CI)
p-value Adjusted
OR (95% CI)
p-value
Age (years)a
17–24 1 0.0463 1 0.7211
25–34 0.70 (0.49–1.00) 0.95 (0.64–1.41)
35–44 1.09 (0.75–1.59) 1.26 (0.83–1.93)
45–54 1.15 (0.78–1.69) 1.14 (0.74–1.76)
55–64 1.19 (0.77–1.83) 1.14 (0.70–1.84)
65 and above 1.40 (0.80–2.42) 0.83 (0.45–1.55)
Gendera
Female 1 0.0035 1 0.5817
Male 0.69 (0.54–0.88) 0.92 (0.69–1.23)
Year of enrolmenta
Dec 2007–2008 1 0.0037 1 0.0177
2009 1.25 (0.75–2.09) 1.83 (1.04–3.23)
2010 0.60 (0.37–0.96) 1.37 (0.79–2.36)
2011 0.91 (0.57–1.44) 2.03 (1.18–3.47)
2012-Feb 2013 0.78 (0.47–1.31) 1.24 (0.70–2.21)
Polyclinic enrolleda
Polyclinic A 1 <0.0001 1 <0.0001
Polyclinic B 0.17 (0.07–0.42) 0.22 (0.09–0.57)
Polyclinic C 0.29 (0.21–0.41) 0.32 (0.22–0.45)
Polyclinic D 0.35 (0.21–0.58) 0.32 (0.18–0.54)
Polyclinic E 1.44 (0.74–2.82) 1.74 (0.80–3.78)
Body Mass Index (kg/m2)
<18.5 1.98 (1.31–2.99) 1.87 (1.19–2.93)
18.5–22.9 1 0.0117 1 0. 0106
23–27.4 1.08 (0.81–1.46) 0.91 (0.66–1.27)
≥27.5 1.86 (1.32–2.60) 1.31 (0.90–1.92)
Housing type
Public housing
(HDB flat)
1 0.0270 1 0.0045
Condominium 1.08 (0.58–2.00) 1.02 (0.51–2.03)
Dormitory/
Hostel
0.19 (0.09–0.37) 0.38 (0.18–0.79)
Landed property 1.47 (0.94–2.28) 1.73 (1.06–2.80)
Work site 0.49 (0.22–1.08) 0.70 (0.30–1.64)
Number of initial symptoms persisting at first follow-up
0 1 0.0414 1 <0.0001
1 2.00 (1.40–2.85) 2.00 (1.38–2.92)
2 2.72 (1.88–3.92) 2.67 (1.80–3.97)
3 4.66 (3.11–6.98) 4.26 (2.73–6.64)
4 and above 2.57 (1.76–3.75) 2.79 (1.84–4.24)
Table 2 Factors Associated with Antibiotic Use among 1884 Fever
Patients at Febrile Polyclinics, December 2007-February 2013
(Continued)
WBC count (cells/μL) at initial visit
Leukopenia (<4) 0.83 (0.51–1.35) 0.61 (0.38–0.99)
Normal range
(4–11)
1 0.0097 1 <0.0001
Leukocytosis
(>11)
1.73 (1.19–2.51) 1.98 (1.42–2.78)
Headache at initial visit
No 1 0.0021 1 0.0239
Yes 0.78 (0.60–1.01) 0.73 (0.54–0.97)
HDB Housing and Development Board, OR odds ratio, WBC white blood cell
aVariables included a priori as covariates in the model
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patterns among patients using primary care services in the
private sector may be different to those in the public sector.
A Malaysian study reported higher antibiotic prescription
among healthcare providers in the private sector compared
to those in the public sector [13]. Inclusion of private
healthcare providers in research studies is important to gain
a comprehensive picture of antibiotic usage in primary
care.
Conclusions
Our study provides insights on antibiotic usage among
adult patients presenting to primary care clinics with
febrile illness, and suggests that high socio-economic sta-
tus, and risk factors of a severe illness, that is, low BMI
and persistence of initial symptoms, are associated with
higher antibiotic use. Further work to understand trends
of antibiotic use, both in the public and private sectors, as
well as factors that influence patient expectation and
physician prescribing of antibiotics is important, in order
to identify opportunities to rationalize antibiotic use and
develop policies for optimal antibiotic use in primary care.
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Table 3 Subgroup Analysis of Patients Who Met the Influenza-like
Illness definition [12] at Polyclinics, December 2007-February 2013
Characteristics Unadjusted
OR (95% CI)
p value Adjusted
OR (95% CI)
p value
Age (years)a
17–24 1 0.6777 1 0.9438
25–34 0.77 (0.46–1.28) 0.84 (0.48–1.49)
35–44 0.96 (0.55–1.70) 0.94 (0.50–1.77)
45–54 0.89 (0.50–1.60) 0.79 (0.41–1.51)
55–64 1.24 (0.69–2.25) 1.11 (0.56–2.17)
65 and above 1.25 (0.55–2.87) 0.92 (0.37–2.34)
Gendera
Female 1 0.0147 1 0.1394
Male 0.64 (0.44–0.91) 0.72 (0.47–1.11)
Year of enrolmenta
Dec 2007–2008 1 0.0021 1 0.0239
2009 0.91 (0.29–2.84) 1.45 (0.42–4.94)
2010 0.37 (0.13–1.12) 0.62 (0.19–1.97)
2011 0.90 (0.31–2.64) 1.20 (0.39–3.71)
2012-Feb 2013 0.56 (0.19–1.68) 0.68 (0.22–2.15)
Polyclinic enrolleda
Polyclinic A 1 <0.0001 1 <0.0001
Polyclinic B 0.22 (0.14–0.37) 0.24 (0.14–0.41)
Polyclinic C 0.39 (0.2–0.77) 0.31 (0.14–0.67)
Polyclinic D
and Eb
0.76 (0.21–2.82) 0.61 (0.15–2.46)
Number of initial visit symptom persisting at first follow-up
0 1 <0.0001 1 <0.0001
1 1.68 (0.96–2.93) 1.42 (0.79–2.57)
2 2.48 (1.38–4.45) 2.30 (1.23–4.30)
3 6.55 (3.59–11.94) 5.12 (2.67–9.83)
4 and above 2.37 (1.34–4.17) 2.28 (1.24–4.19)
WBC count at initial visit (cells/μL)
Leukopenia
(<4)
1.07 (0.57–2.04) 0.99 (0.49–2.01)
Normal range
(4–11)
1 0.1440 1 0.0433
Leukocytosis
(>11)
1.61 (1.01–2.55) 1.97 (1.17–3.33)
OR odds ratio
aVariables included a priori as covariates in the model
bPolyclinic D and E were combined because of low number of patients
(5 and 8 respectively)
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